A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

NCT04109508 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Type 2 Diabetes

Interventions

DRUG: Oral semaglutide

Sponsor

Novo Nordisk A/S